Rigorous physics-based methods to calculate binding free
energies
of protein–ligand complexes have become a valued component
of structure-based drug design. Relative and absolute binding free
energy calculations have been deployed prospectively in support of
solving diverse drug discovery challenges. Here we review recent applications
of binding free energy calculations to fragment growing and linking,
scaffold hopping, binding pose validation, virtual screening, covalent
enzyme inhibition, and positional analogue scanning. Furthermore,
we discuss the merits of using protein models and highlight recent
efforts to replace costly binding free energy calculations with predictions
from machine learning models trained on a limited number of free energy
perturbation or thermodynamic integration calculations thereby allowing
for extended chemical space exploration.